Equities research analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
ADXS stock opened at $0.03 on Thursday. The business’s fifty day simple moving average is $0.03 and its two-hundred day simple moving average is $0.22. Ayala Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $1.49. The firm has a market cap of $1.15 million, a price-to-earnings ratio of 0.00 and a beta of 1.72.
About Ayala Pharmaceuticals
Featured Articles
- Five stocks we like better than Ayala Pharmaceuticals
- How to Invest in Insurance Companies: A Guide
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What to Know About Investing in Penny Stocks
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What is the Dogs of the Dow Strategy? Overview and Examples
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.